Cancer

AI Revolutionizing Industries: Market Set for 39.7% CAGR Growth, Reaching $1.1 Trillion by 2029

"From Healthcare and Life Sciences to Oil & Gas and Diagnostics, BCC Research Highlights How AI is Transforming Industries, Enhancing…

11 months ago

‘The convergence between of AI and the Biology’ LG Creates “Next-Generation Protein Structure Prediction AI” for Drug Discovery

SEOUL, South Korea, Feb. 7, 2025 /PRNewswire/ -- On the 5th, LG AI Research signed a joint research agreement at the…

11 months ago

Izotropic Announces Non-Brokered Private Placement

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia and…

11 months ago

AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM’s Ampligen® and AstraZeneca’s FluMist® to address the recent avian influenza outbreaks

Planned Investigational New Drug application to expand on previous clinical work at the University of Alabama-Birmingham in which administration of…

11 months ago

Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option

FORT LEE, NJ, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on…

11 months ago

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the…

11 months ago

COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration

WEXFORD, Pa., Feb. 6, 2025 /PRNewswire/ -- COEPTIS, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a pioneering technology company dedicated…

11 months ago

Caris Life Sciences to Present at the 2025 ASCO Genitourinary Cancers Symposium

In collaboration with leading cancer centers, research results to be presented from three studies across two tumor types IRVING, Texas,…

11 months ago

CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC Laboratories

VANCOUVER, Washington, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab,…

11 months ago

Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test

SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic…

11 months ago